News: Search results for "Amgen "

» 3 results in Specials» 1 results in Business» 32 results in Health
dotclear

News: Specials

FDA Probes J&J Anemia Drug over Clinical Trial Deaths

FDA Probes J&J Anemia Drug over Clinical Trial Deaths

Results of a study undergone by German scientists revealed that stroke patients given Amgen and...
» read full story September 29th, 2008 - 14:34
FDA To Review Anemia Drug Eprex Following High Rate Of Deaths In Study

FDA To Review Anemia Drug Eprex Following High Rate Of Deaths In Study

The Food and Drug Administration announced on Friday that they are reviewing a higher rate of...
» read full story September 27th, 2008 - 14:36
FDA: J&J’s Psoriasis Drug Might Raise Cancer Risk

FDA: J&J’s Psoriasis Drug Might Raise Cancer Risk

Johnson & Johnson’s experimental drug, ustekinumab appears to be effective in treating...
» read full story June 16th, 2008 - 15:48
dotclear

News: Business

FDA Approves Amgen Inc.'s Nplate Drug For The Fight Against ITP

FDA Approves Amgen Inc.'s Nplate Drug For The Fight Against ITP

On Friday, the Food and Drug Administration (FDA) gave its approval for Amgen Inc.'s drug called...
» read full story August 24th, 2008 - 12:17
dotclear

News: Health

Distinguished Biochemist Robert Tjian Elected as President of Howard Hughes Institute

Distinguished Biochemist Robert Tjian Elected as President of Howard Hughes Institute

Robert Tjian, a distinguished UC Berkley biochemist and gene researcher, has been named president...
» read full story October 01st, 2008 - 14:00
Eprex Anemia Drug Investigated by the FDA

Eprex Anemia Drug Investigated by the FDA

Friday, Federal Drug Administration officials announced the launch of an investigation on...
» read full story September 26th, 2008 - 22:01
New Experimental Drug Much Better For Psoriasis

New Experimental Drug Much Better For Psoriasis

A recent short term trial reached the conclusion that an experimental drug called Ustekinumab,...
» read full story September 21st, 2008 - 14:43
New Revolutionary Drug For Treatment of Psoriasis

New Revolutionary Drug For Treatment of Psoriasis

Johnson & Johnson introduced an experimental drug called ustekinumab that is said to show...
» read full story September 21st, 2008 - 17:43
New Osteoporosis Drug, Amgen’s Denosumab, Reaches Market

New Osteoporosis Drug, Amgen’s Denosumab, Reaches Market

Amgen’s experimental bone drug, called denosumab, was found to reduce the risk of spinal fractures...
» read full story September 19th, 2008 - 15:30
J&J Psoriasis Drug Meets Goal In Trial, Defeats Rival Enbrel

J&J Psoriasis Drug Meets Goal In Trial, Defeats Rival Enbrel

Johnson & Johnson unveiled Thursday results of a late-stage trial that showed its psoriasis...
» read full story September 19th, 2008 - 14:11
Amgen To Release Data On Its Experimental Osteoporosis Drug Denosumab

Amgen To Release Data On Its Experimental Osteoporosis Drug Denosumab

Biotechnology company Amgen Inc. will release the results of the study on its osteoporosis drug...
» read full story September 16th, 2008 - 15:44

FDA Orders Stronger Warnings on Arthritis Drugs

The Food and Drug Administration ordered stronger warnings about the risk of potentially deadly...
» read full story September 05th, 2008 - 14:00

High Blood Calcium Levels Linked To Fatal Prostate Cancer

Men who present high levels of calcium in their bloodstream are more likely to be exposed to an...
» read full story September 03rd, 2008 - 17:03
Drug Ads: Expensive and Ineffective, Canadian Research Shows

Drug Ads: Expensive and Ineffective, Canadian Research Shows

New U.S.-Canadian research shows that direct-to-consumer (DTC) advertising’s effects on drug sales...
» read full story September 02nd, 2008 - 13:30
New ITP Drug Approved By The FDA

New ITP Drug Approved By The FDA

The Food and Drug Administration approved on Friday Nplate, a drug produced by Amgen Inc. which...
» read full story August 25th, 2008 - 12:30
FDA Approves Amgen's Nplate Bone Marrow Stimulant

FDA Approves Amgen's Nplate Bone Marrow Stimulant

Following the recommendation of its expert panel back in March, the Food and Drug Administration...
» read full story August 23rd, 2008 - 15:50
Amgen’s Nplate ITP-Treating Drug Gets FDA Approval

Amgen’s Nplate ITP-Treating Drug Gets FDA Approval

Nplate, Amgen’s drug destined for patients suffering from a rare blood disorder called chronic...
» read full story August 23rd, 2008 - 13:39
FDA Orders Amgen To Change The Labels Of Anemia Drug Aranesp

FDA Orders Amgen To Change The Labels Of Anemia Drug Aranesp

US FDA ordered Amgen Inc on Wednesday to change the labels for Aranesp and similar anemia drugs...
» read full story July 31st, 2008 - 13:49
Drug Combo Improves Rheumatoid Arthritis

Drug Combo Improves Rheumatoid Arthritis

A new study has found that a combination of two drugs, Enbrel and methotrexate, halts progression...
» read full story July 16th, 2008 - 16:11
Amgen’s Bone Drug Meets Endpoint In Phase III Trial

Amgen’s Bone Drug Meets Endpoint In Phase III Trial

Biotech drug manufacturer Amgen Inc. announced on Monday that its experimental drug denosumab...
» read full story July 15th, 2008 - 12:27
Amgen’s VEGF Inhibitor Motesanib Proves Effective in Thyroid Cancer

Amgen’s VEGF Inhibitor Motesanib Proves Effective in Thyroid Cancer

A study published in the July 3 issue of the New England Journal of Medicine reveals that Amgen...
» read full story July 04th, 2008 - 15:28

Enbrel Approved by FDA Panel for Kids with Psoriasis

A Food and Drug Administration advisory panel said Wednesday that wider use of Amgen Inc’s...
» read full story June 20th, 2008 - 18:08
FDA Panel Recommends Amgen’s Enbrel For Kids

FDA Panel Recommends Amgen’s Enbrel For Kids

A FDA panel recommended that the psoriasis drug Enbrel should be approved for the treatment of the...
» read full story June 19th, 2008 - 00:08
Recombinant Drug Enbrel Has Side Effects in Kids

Recombinant Drug Enbrel Has Side Effects in Kids

Recombinant-DNA drug Enbrel, made by Amgen, is apparently worrying the U.S. Food and Drug...
» read full story June 17th, 2008 - 00:08
FDA to Review TNF Blockers for Link to Cancer in Youths

FDA to Review TNF Blockers for Link to Cancer in Youths

The U.S. Food and Drug Administration on Wednesday announced a safety review of several drugs...
» read full story June 05th, 2008 - 10:53
FDA to Probe Drugs Supposedly Connected to Cancer Cases

FDA to Probe Drugs Supposedly Connected to Cancer Cases

The Food and Drug Administration will begin studies to find out if there is any connection between...
» read full story June 04th, 2008 - 19:32
Amgen and Wyeth’s Enbrel to Carry ‘Black Box’ Warning on TB Risk

Amgen and Wyeth’s Enbrel to Carry ‘Black Box’ Warning on TB Risk

Amgen Inc and Wyeth’s Enbrel arthritis and psoriasis drug will carry a new “black box” warning...
» read full story May 02nd, 2008 - 11:59
FDA Panel Votes for Amgen's Nplate Drug

FDA Panel Votes for Amgen's Nplate Drug

A Food and Drug Administration panel voted unanimously today that Amgen Inc.’ Nplate drug, used to...
» read full story March 12th, 2008 - 21:20
FDA to Weigh Benefits and Risks of Amgen Clotting Drug NPLATE

FDA to Weigh Benefits and Risks of Amgen Clotting Drug NPLATE

A Food and Drug Administration panel will vote Wednesday on whether Amgen Inc.’ NPLATE drug to...
» read full story March 11th, 2008 - 12:40
Anemia Drugs’ Use in Cancer Patients Questioned Again

Anemia Drugs’ Use in Cancer Patients Questioned Again

A new study revealed that treating cancer patients with anemia drug increases their risk of blood...
» read full story February 27th, 2008 - 11:40
Anemia Drugs Raise Risk of Death in Cancer Patients

Anemia Drugs Raise Risk of Death in Cancer Patients

A new study published in the February 27, 2008 issue of the Journal of the American Medical...
» read full story February 27th, 2008 - 10:34
ENBREL Effective in Treating Psoriasis in Children as Well

ENBREL Effective in Treating Psoriasis in Children as Well

Amgen, a Thousand Oaks, Calif., biotechnology company and Wyeth Pharmaceuticals, a division of...
» read full story January 17th, 2008 - 13:36
FDA Concerned about New Risks Posed by Anemia Drugs of Amgen and J&J

FDA Concerned about New Risks Posed by Anemia Drugs of Amgen and J&J

The Food and Drug Administration has stated that it is reviewing new data that provide further...
» read full story January 04th, 2008 - 12:40
Amgen New Drug to Prevent Bone Loss in Breast Cancer Patients

Amgen New Drug to Prevent Bone Loss in Breast Cancer Patients

Amgen Inc revealed on Friday that their new osteoporosis drug denosumab increased bone density in...
» read full story December 17th, 2007 - 12:02
FDA Warns Cancer Patients Against Anti-Anemia Drugs

FDA Warns Cancer Patients Against Anti-Anemia Drugs

The U.S Food and Drug Administration warned on Thursday that certain anti-anemia drugs are...
» read full story November 10th, 2007 - 18:08
Anemia Drugs Receive Strengthened Warnings

Anemia Drugs Receive Strengthened Warnings

The Food and Drug Administration approved Thursday revised warnings for several anemia drugs used...
» read full story November 09th, 2007 - 13:03
dotclear
dotclear
dotclear
Photos Gallery
dotclear
Today's Latest News
A Lot of Sunshine, Beauty and Happiness in "Happy-Go-Lucky”A Lot of Sunshine, Beauty and Happiness in "Happy-Go-Lucky”

» read full story
dotclear
Latest videos

Presidential flip-flops

Flip-flops decorated with miniature heads of U.S. Presidential candidates Barack Obama and John McCain have given...

Two more deadly bombs in Pakistan

Around 40 people have been killed in more suicide bombs attacks in Pakistan. Two suicide bombers blew themselves...

Britain's cash boost to Afghan Army

Britain's Prime Minister has promised to put more resources into training the Afghan National Army. Gordon Brown...

Mortgage rates dip, still high

U.S. mortgage rates fell last week, but rates remain high as lenders price in higher premiums for potential...

The future in frame

A new phase of converged devices appears to be upon us, judging from the technologies on display at the 2008 Playbite...


» browse all videos
dotclear